Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTATATE PET/CT in Cardiac Sarcoidosis
NCT03549598Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2018
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoints: 68Ga-DOTATATE Uptake With Cardiac Sarcoidosis at 3 days, 18FDG Uptake With Cardiac Sarcoidosis at 2 days and 1 more. Started Jul 2018; status: completed.
Beyond the preview
Go deeper on NCT03549598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549598.